Xiaomin Lou

Xiaomin Lou


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2015 in Journal of Proteome Research
Verified
Journal Article
Closed access
YZYinghui Zhu
Yinghui Zhu
XCXianwei Chen
Xianwei Chen
QPQingfei Pan
Qingfei Pan
YWYang Wang
Yang Wang
SSSiyuan Su
Siyuan Su
SLSiqi Liu
Siqi Liu

1 October 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XZXu Zhu
Xu Zhu
JZJu Zhang
Ju Zhang
HSHuiying Sun
Huiying Sun
CJCuicui Jiang
Cuicui Jiang
YDYusheng Dong
Yusheng Dong
SLSiqi Liu
Siqi Liu
Deciphering the inositol-requiring enzyme 1 (IRE1) signaling pathway is fundamentally important for understanding the unfolded protein response (UPR). The ubiquitination of proteins residing on the endoplasmic reticulum (ER) membrane has been reported to be involved in the UPR, although the mechanism has yet to be fully elucidated. Using immunoprecipitation and mass spectrometry, IRE1 was identified as a substrate of the E3 ligase CHIP (carboxyl terminus of HSC70-interacting protein) in HEK293 cells under geldanamycin-induced ER stress. Two residues of IRE1, Lys545 and Lys828, were targeted for Lys63-linked ubiquitination. Moreover, in CHIP knockdown cells, IRE1 phosphorylation and the IRE1-TRAF2 interaction were nearly abolished under ER stress, which may be due to lacking ubiquitination of IRE1 on Lys545 and Lys828, respectively. The cellular responses were evaluated, and the data indicated that CHIP-regulated IRE1/TRAF2/JNK signaling antagonized the senescence process. Therefore, our findings suggest that CHIP-mediated ubiquitination of IRE1 contributes to the dynamic regulation of the UPR.

5 May 2014 in Cell Cycle
Verified
Journal Article
Closed access
XLXiaomin Lou
Xiaomin Lou
JZJu Zhang
Ju Zhang
SLSiqi Liu
Siqi Liu
DLD. Joshua Liao
D. Joshua Liao
Although cancer-regulatory genes are dichotomized to oncogenes and tumor-suppressor gene s, in reality they can be oncogenic in one situation but tumor-suppressive in another. This dual-function na...

1 January 2016 in Journal of Proteomics
Verified
Journal Article
Closed access
YWYang Wang
Yang Wang
QSQiang Shan
Qiang Shan
GHGuixue Hou
Guixue Hou
JZJu Zhang
Ju Zhang
JBJian Bai
Jian Bai
SLSiqi Liu
Siqi Liu

Verified
Journal Article
Open access
PDF file
YXYingying Xie
Yingying Xie
SLShuying Li
Shuying Li
LSLei Sun
Lei Sun
SLShujun Liu
Shujun Liu
FWFengzhong Wang
Fengzhong Wang
FXFengjiao Xin
Fengjiao Xin
Lung cancer is a common disease that is associated with poor prognosis. Fungal immunomodulatory protein from Nectria haematococca (FIP-nha) has potential as a lung cancer therapeutic; as such, illuminating its anti-tumor mechanism is expected to facilitate novel treatment options. Here, we showed that FIP-nha affects lung adenocarcinoma growth ex vivo and in vivo. Comparative quantitative proteomics showed that FIP-nha negatively regulates PI3K/Akt signaling and induces cell cycle arrest, autophagy, and apoptosis. We further demonstrated that FIP-nha suppresses Akt phosphorylation, leading to upregulation of p21 and p27 and downregulation of cyclin B1, cyclin D1, CDK2, and CDK4 expression, ultimately resulting in G1/S and G2/M cell cycle arrest. Meanwhile, FIP-nha-induced PI3K/Akt downregulation promotes A549 apoptosis by increasing the expression ratio of Bax/Bcl-2 and c-PARP and autophagy by decreasing the phosphorylation of mTOR. Thus, we comprehensively revealed the anti-tumor mechanism of FIP-nha, which inhibits tumor growth by modulating PI3K/Akt-regulated cell cycle arrest, autophagy, and apoptosis, and provided the basis for further application of fungal immunomodulatory proteins, especially FIP-nha.

11 April 2016 in Oncotarget
Verified
Journal Article
Open access
YXYingying Xie
Yingying Xie
LCLechuang Chen
Lechuang Chen
XLXiaolei Lv
Xiaolei Lv
GHGuixue Hou
Guixue Hou
YWYang Wang
Yang Wang
SLSiqi Liu
Siqi Liu
The levels of serine proteases in colon tissue interstitial fluid and serum serve as an indicator of colorectal cancer progression